NLS Pharmaceutics, a Swiss clinical-stage biopharmaceutical company, has entered into a definitive agreement with BVF PARTNERS to raise aggregate gross proceeds of up to USD 30.0 million in a two-tranche private placement. The net proceeds will
Tags :wnger vieli
The Zurich based aspaara has raised CHF 2 million in their seed financing round to build the next generation ERP that is finally human-centric. The start up aspaara is an Artificial Intelligence (AI) platform that optimises
